These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 39340288)

  • 1. Analysis of the implication of steroid 5 alpha-reductase 3 on prognosis and immune microenvironment in Liver Hepatocellular Carcinoma.
    Lu Y; Liu Z; Zheng Y; Liu X; Liu X; Chen N; Mao K; Lin W
    Ann Med; 2024 Dec; 56(1):2408463. PubMed ID: 39340288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAC1 serves as a prognostic factor and correlated with immune infiltration in liver hepatocellular carcinoma.
    Li Y; Gu A; Yang L; Wang Q
    J Cancer Res Clin Oncol; 2024 Sep; 150(9):418. PubMed ID: 39264423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid 5 alpha-reductase 3 (SRD5A3) promotes tumor growth and predicts poor survival of human hepatocellular carcinoma (HCC).
    Mai Q; Sheng D; Chen C; Gou Q; Chen M; Huang X; Yin H; Chen X; Chen Z
    Aging (Albany NY); 2020 Nov; 12(24):25395-25411. PubMed ID: 33229626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma.
    Qiu C; Li Z; Cao W; Cai X; Ye L; Zhang C; Ma Y; Wang X; Yang Y
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34435618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated Single-cell and Transcriptome Sequencing Analyses Identified PREX1 as an Immune-related Prognostic Biomarker for Liver Hepatocellular Carcinoma.
    Yang J; Fan LY; Shi KY
    Int J Med Sci; 2024; 21(8):1559-1574. PubMed ID: 38903921
    [No Abstract]   [Full Text] [Related]  

  • 6. Comprehensive analysis of N
    Zhu HX; Lu WJ; Zhu WP; Yu S
    J Clin Lab Anal; 2021 Dec; 35(12):e24071. PubMed ID: 34741346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comprehensive roles of lncRNA FAM99A/FAM99B in hepatocellular carcinoma: Expressions, regulatory mechanisms and functional pathway analysis.
    Jin H; Li Y; Qin S; Li Q; Mao Y; Zhao L
    Life Sci; 2024 Jul; 349():122710. PubMed ID: 38740325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOP16 promotes hepatocellular carcinoma progression and triggers EMT through the Keap1-Nrf2 signaling pathway.
    Mu S; Tian Q; Shen L
    Technol Health Care; 2024; 32(4):2463-2483. PubMed ID: 38251077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and immunological potential of PPM1G in hepatocellular carcinoma.
    Lin YR; Yang WJ; Yang GW
    Aging (Albany NY); 2021 May; 13(9):12929-12954. PubMed ID: 33952716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
    Wang R; Hu X; Liu X; Bai L; Gu J; Li Q
    PLoS One; 2021; 16(4):e0249881. PubMed ID: 33861762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma.
    Wang S; Bai H; Fei S; Miao B
    Biochem Genet; 2024 Jun; 62(3):2332-2351. PubMed ID: 37898914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constructing immune and prognostic features associated with ADCP in hepatocellular carcinoma and pan-cancer based on scRNA-seq and bulk RNA-seq.
    Zhang Z; Li Y; Quan Z; Li Y; Zhu L; Sun S; Chen X
    Front Immunol; 2024; 15():1397541. PubMed ID: 38774870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic and antitumor roles of key genes of ferroptosis in liver hepatocellular cancer and stomach adenocarcinoma.
    Pei W; Jiang M; Liu H; Song J; Hu J
    Cancer Biomark; 2024; 39(4):335-347. PubMed ID: 38393890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting PRKDC activates the efficacy of antitumor immunity while sensitizing to chemotherapy and targeted therapy in liver hepatocellular carcinoma.
    Pan Y; Zhu Q; Hong T; Cheng J; Tang X
    Aging (Albany NY); 2024 May; 16(10):9047-9071. PubMed ID: 38787389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scinderin is a potential prognostic biomarker and correlated with immunological regulation: from pan-cancer analysis to liver hepatocellular carcinoma.
    Zhai S; Li Y; Yang Y; Lang W; Liu X; Liu K; Qu J; Zhu L
    Front Immunol; 2024; 15():1361657. PubMed ID: 39108273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the immunity landscape and prognosis with an NCLs signature in liver hepatocellular carcinoma.
    Ji Z; Zhang C; Yuan J; He Q; Zhang X; Yang D; Xu N; Chu J
    PLoS One; 2024; 19(4):e0298775. PubMed ID: 38662757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation Mitochondrial Carrier 1 (MTCH1) Is Associated with Cell Proliferation, Invasion, and Migration of Liver Hepatocellular Carcinoma.
    Chen G; Mo S; Yuan D
    Biomed Res Int; 2021; 2021():9911784. PubMed ID: 34195286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Pyroptosis-Related Gene Signature to Predict Patients' Prognosis and Immune Landscape in Liver Hepatocellular Carcinoma.
    Wang J; Huang Z; Lu H; Zhang R; Feng Q; He A
    Comput Math Methods Med; 2022; 2022():1258480. PubMed ID: 35242200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dichotomous roles of ADAR1 in liver hepatocellular carcinoma and kidney renal cell carcinoma: Unraveling the complex tumor microenvironment and prognostic significance.
    Mao JX; Li JJ; Lu XY; Zhong HX; Zhao YY; Zhu LY; Fu H; Ding GS; Teng F; Chen M; Guo WY
    Int Immunopharmacol; 2024 Jul; 136():112340. PubMed ID: 38820962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of YBX1 role in the prognostic value and immune characteristics by single-cell and bulk sequencing analysis for liver hepatocellular carcinoma.
    Zhang Q; Zhu B; Yang H; Li F; Qu Y; Lu L; Zhang Q
    J Gene Med; 2024 Mar; 26(3):e3680. PubMed ID: 38448368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.